[Resection of Oligometastasis Liver Metastases from Breast Cancer-Two-Case Report].

Q4 Medicine
Yusuke Nishio, Satoshi Matsukuma, Shigeru Yamamoto, Masaki Iwado, Hiroaki Yamatani, Daiki Haraguchi, Atomu Suzuki, Naohiro Yamamoto, Sota Yoshimine, Kazuhisa Tokuno, Toru Kawaoka, Hisashi Sakano, Yuji Fujita, Norio Akiyama
{"title":"[Resection of Oligometastasis Liver Metastases from Breast Cancer-Two-Case Report].","authors":"Yusuke Nishio, Satoshi Matsukuma, Shigeru Yamamoto, Masaki Iwado, Hiroaki Yamatani, Daiki Haraguchi, Atomu Suzuki, Naohiro Yamamoto, Sota Yoshimine, Kazuhisa Tokuno, Toru Kawaoka, Hisashi Sakano, Yuji Fujita, Norio Akiyama","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Resection of liver metastases from breast cancer is not widely accepted because the survival benefit of surgery has not been demonstrated. We report the cases of 2 patients who underwent resection of liver metastases from breast cancer. Case 1: This was a female patient in her 50s with synchronous metastasis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Resection was performed since the patient had exhausted all anti-HER2 therapies and had only a single liver metastasis. Immunohistochemical staining results of the resected specimens showed HER2 negativity. The patient had no recurrence 5 months postoperatively and received adjuvant chemotherapy with capecitabine. Case 2: This was a female patient in her 70s with metachronous metastasis of hormone receptor-positive disease. A single liver metastasis occurred 28 years after the primary tumor resection. During the 2-year hormone therapy, no new lesions appeared, and the tumor was stable; therefore, resection was performed. The resected specimen showed a complete pathological response. Furthermore, the patient has been recurrence-free for 1 year without any therapy.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 3","pages":"260-262"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Resection of liver metastases from breast cancer is not widely accepted because the survival benefit of surgery has not been demonstrated. We report the cases of 2 patients who underwent resection of liver metastases from breast cancer. Case 1: This was a female patient in her 50s with synchronous metastasis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Resection was performed since the patient had exhausted all anti-HER2 therapies and had only a single liver metastasis. Immunohistochemical staining results of the resected specimens showed HER2 negativity. The patient had no recurrence 5 months postoperatively and received adjuvant chemotherapy with capecitabine. Case 2: This was a female patient in her 70s with metachronous metastasis of hormone receptor-positive disease. A single liver metastasis occurred 28 years after the primary tumor resection. During the 2-year hormone therapy, no new lesions appeared, and the tumor was stable; therefore, resection was performed. The resected specimen showed a complete pathological response. Furthermore, the patient has been recurrence-free for 1 year without any therapy.

[乳腺癌寡转移肝转移灶切除术--两例报告]。
切除乳腺癌肝转移瘤尚未被广泛接受,因为手术对生存的益处尚未得到证实。我们报告了2例接受乳腺癌肝转移灶切除术的患者。病例1:这是一位50多岁的女性患者,伴有人表皮生长因子受体2 (HER2)阳性乳腺癌的同步转移。由于患者用尽了所有抗her2治疗方法,并且只有一个肝转移,因此进行了切除。切除标本免疫组化染色结果显示HER2阴性。术后5个月无复发,接受卡培他滨辅助化疗。病例2:这是一位70多岁的女性患者,伴有激素受体阳性疾病的异时转移。原发肿瘤切除后28年发生单一肝转移。2年激素治疗期间未出现新病灶,肿瘤稳定;因此,行手术切除。切除的标本表现出完全的病理反应。此外,患者在未接受任何治疗的情况下已有1年无复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信